Litcius/Paper detail

Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma

James A. Davis, Danai Dima, Nausheen Ahmed, Shaun DeJarnette, Joseph P. McGuirk, Xuefei Jia, Shahzad Raza, Jack Khouri, Jason Valent, Faiz Anwer, Al‐Ola Abdallah, Hamza Hashmi

2023Transplantation and Cellular Therapy38 citationsDOI

Topics & Concepts

MedicineInternal medicineMultiple myelomaCytokine release syndromeChimeric antigen receptorHematopoietic stem cell transplantationIncidence (geometry)OncologyRefractory (planetary science)ComorbidityTransplantationLenalidomideGastroenterologyImmunotherapyCancerBiologyAstrobiologyPhysicsOpticsCAR-T cell therapy researchSemiconductor materials and devicesAdvancements in Semiconductor Devices and Circuit Design
Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma | Litcius